BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8738587)

  • 21. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study.
    Kakkar VV; Murray WJ
    Br J Surg; 1985 Oct; 72(10):786-91. PubMed ID: 3899240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of the low-molecular-weight heparin CY 216 in the prevention of fatal pulmonary embolism and thromboembolic death in general surgery. A multicentre, double-blind, randomized, controlled clinical trial versus placebo (STEP). STEP Study Group.
    Pezzuoli G; Neri Serneri GG; Settembrini PG; Coggi G; Olivari N; Negri G; Codemo R; Galli G; Roveri S
    Haemostasis; 1990; 20 Suppl 1():193-204. PubMed ID: 1964662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
    Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dalteparin versus unfractionated heparin in critically ill patients.
    ; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
    N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.
    Simonneau G; Sors H; Charbonnier B; Page Y; Laaban JP; Azarian R; Laurent M; Hirsch JL; Ferrari E; Bosson JL; Mottier D; Beau B
    N Engl J Med; 1997 Sep; 337(10):663-9. PubMed ID: 9278462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism.
    Anderson DR; O'Brien BJ
    Pharmacoeconomics; 1997 Jul; 12(1):17-29. PubMed ID: 10169385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of perioperative deep vein thrombosis in general surgery: a multicentre double blind study comparing two doses of Logiparin and standard heparin. H.B.P.M. Research Group.
    Liezorovicz A; Picolet H; Peyrieux JC; Boissel JP
    Br J Surg; 1991 Apr; 78(4):412-6. PubMed ID: 1851649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of post-operative thromboembolism in general surgery with enoxaparin: preliminary findings.
    Haas S; Flosbach CW
    Acta Chir Scand Suppl; 1990; 556():96-102. PubMed ID: 1963023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
    Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orgaran in the prevention of deep vein thrombosis in stroke patients.
    Turpie AG
    Haemostasis; 1992; 22(2):92-8. PubMed ID: 1379969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
    Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G
    N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial.
    von Tempelhoff GF; Harenberg J; Niemann F; Hommel G; Kirkpatrick CJ; Heilmann L
    Int J Oncol; 2000 Apr; 16(4):815-24. PubMed ID: 10717252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of unfractionated heparin for thromboembolism prophylaxis in medical patients.
    Yalamanchili K; Sukhija R; Sinha N; Aronow WS; Maguire GP; Lehrman SG
    Am J Ther; 2005; 12(4):293-9. PubMed ID: 16041191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
    ; Büller HR; Gent M; Gallus AS; Ginsberg J; Prins MH; Baildon R
    N Engl J Med; 1997 Sep; 337(10):657-62. PubMed ID: 9280815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration.
    Schrader J; Stibbe W; Armstrong VW; Kandt M; Muche R; Köstering H; Seidel D; Scheler F
    Kidney Int; 1988 Apr; 33(4):890-6. PubMed ID: 2838681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke.
    Gallus AS
    Haemostasis; 2000; 30 Suppl 2():64-71; discussion 63. PubMed ID: 11251344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.